6515--diagnostic radiotracer for beta amyloid protein used for Alzheimer's patients.
ID: 36C26225Q0406Type: Combined Synopsis/Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF262-NETWORK CONTRACT OFFICE 22 (36C262)Gilbert, AZ, 85297, USA

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/b8e0ec2f625149f89a0fc5d9ec83dc54/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of a diagnostic radiotracer specifically designed for detecting beta amyloid protein in Alzheimer's patients. The primary objective is to acquire the FDA-approved 18-Florbetaben (Neuraceq) for use in positron emission tomography (PET) imaging, with a minimum order of 15 units expected. This acquisition is crucial for enhancing diagnostic capabilities in Alzheimer's care, reflecting the federal government's commitment to improving patient outcomes. Interested vendors should submit inquiries by January 30, 2025, and proposals must be submitted by the response deadline of February 3, 2025, with the contract to be awarded on a firm-fixed-price basis.

    Point(s) of Contact
    DEBBY ABRAHAMCONTRACTING OFFICER
    (562) 766-2234
    DEBBY.ABRAHAM@VA.GOV
    Files
    Title
    Posted
    S02_RFQ 36C26225Q0406 DIAGNOSTIC RADIOTRACER FOR ALZHEIMER PATIENTS.pdf
    This document outlines a Request for Proposals (RFP) by the Department of Veterans Affairs (VA) for a diagnostic radiotracer specifically designed for beta amyloid protein detection in Alzheimer's patients. The primary focus is on procuring the FDA-approved 18-Florbetaben (Neuraceq) for positron emission tomography (PET) imaging. The solicitation number is 36C26225Q0406, with a response deadline set for February 3, 2025. The awarded contract will follow a firm-fixed-price model, and at least 15 units are expected. Key requirements include compatibility with the Nuclear Medicine Information System, maintenance of safety compliance as per various regulatory agencies, and timely communication regarding product recalls or safety concerns. The performance period will be confirmed later, and deliveries are expected at the Greater Los Angeles VA Medical Center during standard working hours. Interested vendors are advised to submit inquiries regarding the RFP by January 30, 2025. This acquisition highlights the federal government's commitment to enhancing Alzheimer's patient care through improved diagnostic capabilities.
    Lifecycle
    Title
    Type
    6515--diagnostic radiotracer for beta amyloid protein used for Alzheimer's patients.
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    6525--SEP 2024 Equipment Only Consolidation - Amendment 0004
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of medical imaging equipment as part of the "September 2024 Equipment Only Consolidation" initiative. This opportunity includes various ultrasound systems and imaging devices aimed at enhancing diagnostic capabilities across multiple Veterans Affairs Medical Centers, with specific requirements for technical specifications, training, and service support. The equipment is critical for improving healthcare delivery to veterans, ensuring compliance with federal standards and operational efficiency. Interested vendors must submit their proposals by February 5, 2025, and can direct inquiries to Contracting Officer Teresa Rogofsky at teresa.rogofsky@va.gov.
    6505--Bevacizumab Injection
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to procure Bevacizumab Injections through a Request for Proposal (RFP) designated as 36E79725R0019. This procurement aims to secure an uninterrupted supply of Bevacizumab, a critical pharmaceutical product used in the treatment of various medical conditions, for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The contract will span one year with four additional one-year option periods, and the estimated annual requirements include various package sizes of Bevacizumab, with a total estimated usage of over 100,000 vials. Interested offerors must submit their proposals by March 4, 2025, at 2:30 PM Central Time, and can direct inquiries to Contract Specialist Matthew Poulin at Matthew.Poulin@va.gov or by phone at 708-786-5186.
    6505--Rituximab and Biosimilars
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) designated as 36E79725R0021 for the procurement of Rituximab and its biosimilars, aimed at ensuring a reliable supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will span one year with four additional one-year options, emphasizing the necessity of maintaining an uninterrupted supply chain for these critical medications. Offerors must provide the exact product names along with unique National Drug Codes (NDC), with estimated annual requirements of 17,858 vials of Rituximab 10mg/ml and 25,111 vials of the 50mg/ml variant. The solicitation is expected to be published around February 17, 2025, with a closing date around March 4, 2025; interested parties should direct inquiries to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Mycophenolate Mofetil RFP
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) numbered 36E79725R0010 for the procurement of Mycophenolate Mofetil tablets and capsules, intended for use by the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to secure a reliable source of supply for these essential medications, with a contract term of one year and the option to extend for four additional years, emphasizing the importance of uninterrupted access to critical pharmaceuticals for veterans and associated federal programs. Interested offerors must comply with specific packaging requirements, including child-resistant closures for smaller bottles, and are encouraged to check the designated URL for updates, with the solicitation expected to be issued around February 14, 2025, and offers accepted until February 28, 2025. For inquiries, potential bidders can contact Amber Zavala at amber.zavala@va.gov or by phone at (708) 786-5245.
    6525--DEC 2024 Equipment Only Consolidation
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the December 2024 Equipment Only Consolidation, aimed at procuring essential medical equipment for its operations. This solicitation is restricted to companies that currently hold contracts for designated equipment types with the VA National Acquisition Center or the Defense Logistics Agency, with a focus on items such as X-ray machines, ultrasound devices, and CT scanners across various Veterans Integrated Service Networks (VISN). The procurement process is critical for enhancing healthcare services within the VA system, ensuring that facilities are adequately equipped to serve veterans effectively. Interested vendors must submit their offers by April 9, 2025, with the goal of awarding delivery orders by August 12, 2025; for further inquiries, contact Contract Specialist Hermann A Degbegni at hermann.degbegni@va.gov or 708-786-5812.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Baclofen Tablets under the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while complying with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is crucial for maintaining the pharmaceutical needs of VA facilities, addressing issues such as compliance, backorders, and recalls. Interested offerors must submit their proposals by February 5, 2025, at 2:30 PM CST, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6525--NX EQ Ultrasound Guided Fusion Biopsy System (VA-25-00042216)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify qualified vendors capable of supplying an Ultrasound Guided Fusion Biopsy System, specifically the Philips Healthcare UroNav MR or equivalent. The procurement aims to establish a Requirements Contract for nationwide delivery of the system to VA medical centers, with an anticipated duration of one base year and four optional extension periods. This advanced imaging system is crucial for enhancing minimally invasive biopsy procedures, providing real-time imaging and various biopsy approaches, while ensuring compliance with FDA regulations. Interested vendors must submit their responses, including technical literature and service plan details, to Alex Beck at Alex.Beck1@va.gov by the specified deadline, as this notice is part of the VA's ongoing market research efforts.
    6505--Phenytoin SA Capsules (VA-25-00022318)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to issue a Request for Proposal (RFP) for the procurement of Phenytoin Sodium Extended 100MG Sustained Action Capsules, designated as solicitation number 36E79725R0016. This unrestricted contract aims to ensure a reliable supply of these essential medications for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with one contract awarded for an initial period of one year and the option for four additional one-year periods. The estimated annual requirement is approximately 16,653 units, highlighting the critical need for uninterrupted supply to support service members and associated organizations. Interested offerors should submit their proposals by March 7, 2025, following the electronic issuance of the RFP on or about February 21, 2025, and may direct inquiries to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Tamsulosin Hydrochloride capsules as part of its Pharmaceutical Prime Vendor (PPV) Programs. Offerors are required to submit pricing for a base year and four option years, ensuring compliance with FDA standards and providing a unique 11-digit National Drug Code (NDC) for each product. This procurement is vital for maintaining a consistent supply of necessary pharmaceuticals to federal healthcare facilities, adhering to regulatory standards while ensuring availability and pricing stability. Interested parties must submit their offers by February 24, 2025, at 2:30 PM CST, and can contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.